Copyright
©The Author(s) 2025.
World J Clin Oncol. May 24, 2025; 16(5): 105881
Published online May 24, 2025. doi: 10.5306/wjco.v16.i5.105881
Published online May 24, 2025. doi: 10.5306/wjco.v16.i5.105881
Table 3 Excluded studies
Ref. | Study type | Treatment favored (OS) |
Chong et al[11] | Retrospective comparative study | Resection |
Chua et al[12] | Retrospective comparative study | Resection |
Hsiao et al[15] | Retrospective comparative study | Resection |
Kim et al[16] | Retrospective comparative study | No difference |
Lai et al[17] | Retrospective comparative study | Resection/no difference |
Liu et al[19] | Retrospective comparative study | Resection |
Ng et al[21] | Randomized clinical trial | No difference |
Song et al[24] | Retrospective comparative study | No difference |
Song et al[23] | Randomized clinical trial | No difference |
Wang et al[27] | Retrospective comparative study | Ablation/no difference |
Wei et al[28] | Retrospective comparative study | Resection |
Ye et al[30] | Retrospective comparative study | No difference/resection |
- Citation: Cicerone O, Mantovani S, Oliviero B, Basilico G, Corallo S, Quaretti P, Maestri M. Navigating the evidence for hepatocellular carcinoma treatment: Surgery vs radiofrequency ablation through sentiment and meta-analysis. World J Clin Oncol 2025; 16(5): 105881
- URL: https://www.wjgnet.com/2218-4333/full/v16/i5/105881.htm
- DOI: https://dx.doi.org/10.5306/wjco.v16.i5.105881